| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-09 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-08 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.21 | 9e-08 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-07 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.24 | 2e-07 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-07 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |